NASDAQ:OPK OPKO Health (OPK) Stock Price, News & Analysis $1.63 0.00 (0.00%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$1.62 -0.01 (-0.92%) As of 10/23/2026 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About OPKO Health Stock (NASDAQ:OPK) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OPKO Health alerts:Sign Up Key Stats Today's Range$1.60▼$1.6550-Day Range$1.32▼$1.7352-Week Range$0.98▼$1.77Volume1.80 million shsAverage Volume5.29 million shsMarket Capitalization$1.22 billionP/E RatioN/ADividend YieldN/APrice Target$2.96Consensus RatingModerate Buy Company Overview OPKO Health, Inc. is a healthcare company focused on diagnostics and pharmaceuticals. Through its BioReference Laboratories business, the company provides clinical laboratory services, including routine testing, specialty diagnostics, genetic testing and oncology-related laboratory services. OPKO also develops diagnostic products, including the 4Kscore test, a blood test designed to help assess the risk of aggressive prostate cancer. In pharmaceuticals, OPKO develops treatments for kidney disease, endocrine disorders and other conditions. Its products include Rayaldee, an extended-release calcifediol formulation used to treat secondary hyperparathyroidism in adults with chronic kidney disease, and NGENLA, a long-acting human growth hormone product developed with Pfizer for certain children with growth hormone deficiency. OPKO also maintains a pipeline of investigational therapies and biologic products. OPKO serves patients, healthcare providers and commercial partners in the United States and select international markets through its laboratory, pharmaceutical and biotechnology operations. The company is led by Phillip Frost, who serves as chairman and chief executive officer. OPKO has expanded its business over time through the development and acquisition of diagnostic and pharmaceutical assets, including BioReference Laboratories.AI Generated. May Contain Errors. Read More OPKO Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks65th Percentile Overall ScoreOPK MarketRank™: 3.229389721625 of 5 starsOPKO Health scored higher than 65% of companies evaluated by MarketBeat, and ranked 296th out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingOPKO Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 1 strong buy rating, 4 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialOPKO Health has a consensus price target of $2.96, representing about 81.7% upside from its current price of $1.63.Amount of Analyst CoverageOPKO Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about OPKO Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for OPKO Health are expected to decrease in the coming year, from ($0.23) to ($0.27) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OPKO Health is -18.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of OPKO Health is -18.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOPKO Health has a P/B Ratio of 0.98. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about OPKO Health's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.62% of the float of OPKO Health has been sold short.Short Interest Ratio / Days to CoverOPKO Health has a short interest ratio ("days to cover") of 14.94, which indicates bearish sentiment.Change versus previous monthShort interest in OPKO Health has recently decreased by 1.19%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOPKO Health does not currently pay a dividend.Dividend GrowthOPKO Health does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment0.66 News SentimentOPKO Health has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 15 news articles for OPKO Health this week, compared to 5 articles on an average week.Search InterestOnly 5 people have searched for OPK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows7 people have added OPKO Health to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, OPKO Health insiders have not sold or bought any company stock.Percentage Held by Insiders44.72% of the stock of OPKO Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.63% of the stock of OPKO Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about OPKO Health's insider trading history. Receive OPK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OPKO Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OPK Stock News HeadlinesOPKO Health consensus price target decreased by 14.14% to $4.23October 23 at 3:02 PM | msn.comOPKO Health consensus price target decreased by 14.14% to $4.23October 23 at 3:02 PM | msn.com$29.97 or $0 todayThe 0DTE Game Plan normally sells for 29.97, but it is free today through this link. Inside is a straightforward 3-step approach to trading same-day options, with entry, exit and max loss set before you ever place a trade. Plain English, no complicated math, done by market close. The price may return to 29.97 as soon as tomorrow.October 24 at 1:00 AM | Profits Run (Ad)FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKIOctober 23 at 3:02 PM | finance.yahoo.comSOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.TherapyOctober 23 at 3:02 PM | finance.yahoo.comRevvity Launches Signals LabGistics to Coordinate Scientific WorkflowsOctober 22 at 2:51 PM | finance.yahoo.comGEHC Expands Theranostics Imaging With 5 Global CollaborationsOctober 22 at 2:51 PM | finance.yahoo.comStryker's Sonopet 3 Secures FDA Clearance to Improve Surgical AccuracyOctober 21 at 1:22 PM | finance.yahoo.comSee More Headlines OPK Stock Analysis - Frequently Asked Questions How have OPK shares performed this year? OPKO Health's stock was trading at $1.26 at the start of the year. Since then, OPK stock has increased by 29.4% and is now trading at $1.63. How were OPKO Health's earnings last quarter? OPKO Health, Inc. (NASDAQ:OPK) issued its quarterly earnings results on Monday, July, 27th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.08) by $0.07. The company's quarterly revenue was up 4.3% compared to the same quarter last year. Read the conference call transcript. How do I buy shares of OPKO Health? Shares of OPK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of OPKO Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that OPKO Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Micron Technology (MU), Advanced Micro Devices (AMD), Pfizer (PFE) and Gilead Sciences (GILD). Company Calendar Last Earnings7/27/2026Today10/23/2026Next Earnings (Estimated)11/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 10 days, OPK's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:OPK CIK944809 Webwww.opko.com Phone(305) 575-4100Fax305-575-6015Employees1,373Year Founded2007Price Target and Rating Average Price Target for OPKO Health$2.96 High Price Target$4.00 Low Price Target$1.60 Potential Upside/Downside+81.7%Consensus RatingModerate Buy Rating Score (0-4)2.63 Research Coverage8 Analysts Profitability EPS (Trailing Twelve Months)($0.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$225.68 million Net Margins-12.40% Pretax Margin-13.58% Return on Equity-5.88% Return on Assets-3.83% Debt Debt-to-Equity Ratio0.28 Current Ratio3.35 Quick Ratio2.93 Sales & Book Value Annual Sales$606.90 million Price / Sales2.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.67 per share Price / Book0.98Miscellaneous Outstanding Shares746,330,000Free Float412,570,000Market Cap$1.22 billion OptionableOptionable Beta1.51 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:OPK) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored$29.97 or $0 todayThe 0DTE Game Plan normally sells for 29.97, but it is free today through this link. Inside is a straightfo...Profits Run | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OPKO Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
